ENTITY
Laurus Labs

Laurus Labs (LAURUS IN)

86
Analysis
Health Care • India
Laurus Labs is a research-driven, integrated pharmaceutical and biotechnology company specializing in Active Pharmaceutical Ingredients (APIs), generic formulations, and Contract Development and Manufacturing Organization (CDMO) services. The company is a global leader in antiretroviral (ARV) APIs and has diversified into oncology, cardiovascular, and biotechnology segments. Laurus Labs is headquartered in Hyderabad, India, and was founded in 2005.
more
bullish•Laurus Labs
•07 Oct 2026 08:30

Laurus Labs: 3 Core Catalyst Behind The Growth Runway

Laurus Labs has moved beyond the FY24 earnings trough. The next leg depends on whether peptides, late-stage CDMO programmes and an unusually heavy...

Logo
88 Views
Share
bullish•Laurus Labs
•08 Aug 2026 07:52

Primer: Laurus Labs (LAURUS IN) - Aug 2026

Laurus Labs is transitioning from a pure-play Active Pharmaceutical Ingredients (API) manufacturer, with a historical concentration in...

Logo
93 Views
Share
•13 Aug 2026 07:34

Global Index: Potential Changes in August for Asia Pac

The global index changes were announced using D1 as the cutoff. 99% hit rate across Asia Pacific, so no surprises. Big price changes in the stocks...

Logo
349 Views
Share
•04 Jan 2025 16:43

Anthem Biosciences Pre-IPO: High Visibility Powered by Differentiated Capabilities

Anthem Biosciences, a Contract Research, Development, and Manufacturing Organization, has filed DRHP for an Indian IPO. The proposed IPO will be...

Logo
879 Views
Share
bullish•Laurus Labs
•29 Jun 2026 09:39

NIFTY200 Momentum30 / Nifty100 LowVol30 Index Rebalance: Over US$2bn to Trade in June

The deletes have outperformed the adds by 4.7% since the announcement of the changes. The passives trade at the close today and those flows could...

Logo
201 Views
Share
x